Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Mitochondrial Complex I Inhibition by Metformin Limits Reperfusion Injury.

Mohsin AA, Chen Q, Quan N, Rousselle T, Maceyka MW, Samidurai A, Thompson J, Hu Y, Li J, Lesnefsky EJ.

J Pharmacol Exp Ther. 2019 May;369(2):282-290. doi: 10.1124/jpet.118.254300. Epub 2019 Mar 7.

PMID:
30846619
2.

Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.

Samidurai A, Kukreja RC, Das A.

Oxid Med Cell Longev. 2018 Aug 23;2018:6141902. doi: 10.1155/2018/6141902. eCollection 2018. Review.

3.

Deciphering Non-coding RNAs in Cardiovascular Health and Disease.

Das A, Samidurai A, Salloum FN.

Front Cardiovasc Med. 2018 Jul 2;5:73. doi: 10.3389/fcvm.2018.00073. eCollection 2018. Review.

4.

Chronic treatment with novel nanoformulated micelles of rapamycin, Rapatar, protects diabetic heart against ischaemia/reperfusion injury.

Samidurai A, Salloum FN, Durrant D, Chernova OB, Kukreja RC, Das A.

Br J Pharmacol. 2017 Dec;174(24):4771-4784. doi: 10.1111/bph.14059. Epub 2017 Nov 24.

5.

The influence of mandatory iodine fortification on the iodine status of Australian school children residing in an iodine sufficient region.

Samidurai AJ, Ware RS, Davies PS.

Asia Pac J Clin Nutr. 2017;26(4):680-685. doi: 10.6133/apjcn.052016.04.

6.

Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK.

Filippone SM, Samidurai A, Roh SK, Cain CK, He J, Salloum FN, Kukreja RC, Das A.

Oxid Med Cell Longev. 2017;2017:4619720. doi: 10.1155/2017/4619720. Epub 2017 Mar 8.

7.

The Iodine Status of Queensland Preschool Children After the Introduction of Mandatory Iodine Fortification in Bread: An Exploratory Study Using a Convenience Sample.

Samidurai AJ, Ware RS, Davies PS.

Matern Child Health J. 2017 Jan;21(1):215-221. doi: 10.1007/s10995-016-2111-0.

PMID:
27514390
8.

Right ventricular outflow tract assessment: Identification of right ventricle dysfunction in heart failure.

Torrado JF, Samidurai A.

Indian Heart J. 2016 Apr;68 Suppl 1:S5-7. doi: 10.1016/j.ihj.2015.08.028. Epub 2015 Nov 6. No abstract available.

9.

Advantages of collecting multiple urinary iodine concentrations when assessing iodine status of a population.

Samidurai AJ, Ware RS, Davies PS.

Acta Paediatr. 2015 Nov;104(11):e524-9. doi: 10.1111/apa.13168.

PMID:
26317993
10.

Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα.

Das A, Samidurai A, Hoke NN, Kukreja RC, Salloum FN.

Basic Res Cardiol. 2015;110(4):42. doi: 10.1007/s00395-015-0500-y. Epub 2015 Jun 3.

PMID:
26036467
11.

Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice.

Toldo S, Das A, Mezzaroma E, Chau VQ, Marchetti C, Durrant D, Samidurai A, Van Tassell BW, Yin C, Ockaili RA, Vigneshwar N, Mukhopadhyay ND, Kukreja RC, Abbate A, Salloum FN.

Circ Cardiovasc Genet. 2014 Jun;7(3):311-20. doi: 10.1161/CIRCGENETICS.113.000381. Epub 2014 May 13.

12.

Short term variability in urinary bisphenol A in Australian children.

Heffernan AL, Aylward LL, Samidurai AJ, Davies PS, Toms LM, Sly PD, Mueller JF.

Environ Int. 2014 Jul;68:139-43. doi: 10.1016/j.envint.2014.03.027. Epub 2014 Apr 14.

PMID:
24727068
13.

Nuclear localization of vascular endothelial growth factor-D and regulation of c-Myc-dependent transcripts in human lung fibroblasts.

El-Chemaly S, Pacheco-Rodriguez G, Malide D, Meza-Carmen V, Kato J, Cui Y, Padilla PI, Samidurai A, Gochuico BR, Moss J.

Am J Respir Cell Mol Biol. 2014 Jul;51(1):34-42. doi: 10.1165/rcmb.2013-0417OC.

14.

Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.

Salloum FN, Das A, Samidurai A, Hoke NN, Chau VQ, Ockaili RA, Stasch JP, Kukreja RC.

Am J Physiol Heart Circ Physiol. 2012 Mar 15;302(6):H1347-54. doi: 10.1152/ajpheart.00544.2011. Epub 2012 Jan 20.

15.

Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury.

Dumitrascu R, Koebrich S, Dony E, Weissmann N, Savai R, Pullamsetti SS, Ghofrani HA, Samidurai A, Traupe H, Seeger W, Grimminger F, Schermuly RT.

BMC Pulm Med. 2008 Dec 17;8:25. doi: 10.1186/1471-2466-8-25.

16.

Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.

Schermuly RT, Pullamsetti SS, Kwapiszewska G, Dumitrascu R, Tian X, Weissmann N, Ghofrani HA, Kaulen C, Dunkern T, Schudt C, Voswinckel R, Zhou J, Samidurai A, Klepetko W, Paddenberg R, Kummer W, Seeger W, Grimminger F.

Circulation. 2007 May 1;115(17):2331-9. Epub 2007 Apr 16.

PMID:
17438150
17.

Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.

Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W, Grimminger F.

Circ Res. 2004 Apr 30;94(8):1101-8. Epub 2004 Mar 18.

PMID:
15031263

Supplemental Content

Loading ...
Support Center